What was recalled
The U.S. Food and Drug Administration (FDA) has issued a significant Class II recall affecting a specific batch of prescription medication distributed nationwide. This action involves Levothyroxine Sodium Tablets, USP, specifically the 300 mcg (0.3 mg) strength. These are not over-the-counter supplements but strict prescription-only medications, meaning they require a doctor’s authorization and are typically dispensed by licensed pharmacies. The product is manufactured for Accord Healthcare, Inc., which maintains its operational base in Raleigh, North Carolina, with the postal code 27617 listed as part of their official address. However, the physical manufacturing process was carried out by Intas Pharmaceuticals Limited, located at Camp Road in Selaqui, Dehradun, India (postal code 248 197). This international supply chain detail is important for tracking the specific origin of the affected units.
The precise scope of this recall is defined by strict lot and expiration criteria. Only bottles containing Lot number D2402337 are subject to this notice. These particular bottles are packaged in 90-count containers, a standard bulk size often prescribed for long-term management of thyroid conditions. The expiration date printed on these specific units is October 31, 2026. It is critical to note that Levothyroxine Tablets from other lots, different strengths, or bottles manufactured by other facilities are not included in this recall unless they share the exact Lot number D2402337. The National Drug Code (NDC) for these affected bottles is 16729-458-15. If you have medication with a different NDC, it is likely from a separate production run and not part of this specific issue.
This recall was officially initiated on August 6, 2026. At the time of the announcement, the affected inventory had been distributed to pharmacies and healthcare providers across all fifty states within the United States. Because the distribution pattern is nationwide, patients in any state could potentially possess this medication if it was dispensed from a pharmacy that received stock from Accord Healthcare prior to the recall date. The classification of this recall as Class II indicates that use or exposure to the violative product may cause temporary, medically reversible, health consequences, or where the probability of serious adverse health consequences is remote. However, given that Levothyroxine is a hormone replacement drug, any deviation from its expected potency can have immediate and noticeable effects on a patient’s metabolic regulation and overall well-being.
Understanding exactly what was recalled helps prevent unnecessary panic while ensuring that those who truly need to take action do so promptly. The combination of the specific manufacturer (Intas Pharmaceuticals), the specific packager (Accord Healthcare), the exact lot number (D2402337), and the precise expiration date (10/31/2026) creates a narrow, identifiable window of affected products. If you are unsure whether your bottle is part of this group, the first step is to locate the lot number printed on the side or back of the prescription bottle label. Comparing this number against the recalled lot D2402337 is the only definitive way to determine if your specific medication is included in this FDA action.
The hazard, explained
To understand why this recall matters, we first need to look at what “subpotent” actually means in the context of pharmaceuticals. In simple terms, a subpotent drug contains less of the active ingredient than it claims on the label. For Levothyroxine Sodium Tablets, USP, 300 mcg, the expectation is that each pill delivers exactly 300 micrograms of thyroid hormone to your body. When a batch is subpotent, that number drops below the target. This isn’t about impurities or contamination; it is about quantity. The chemical structure of the drug is likely correct, but there simply isn’t enough of it in each tablet to do the job it was designed to do.
This specific issue affects a medication that manages one of the body’s most critical metabolic engines: your thyroid. Levothyroxine is a synthetic version of thyroxine (T4), a hormone produced by your thyroid gland. This hormone acts like the master regulator for your metabolism, influencing how your cells use energy, how fast your heart beats, and even how your brain functions. Because the thyroid controls so many systems simultaneously, the body relies on precise, consistent dosing to maintain homeostasis—the delicate balance of internal stability. When you take Levothyroxine, you are essentially replacing what your body cannot make in sufficient quantities. If that replacement is weaker than prescribed, your body doesn’t just get “a little less” help; it gets a significantly reduced signal to regulate its core functions.
The mechanism of harm here is cumulative and physiological. Thyroid hormone levels do not fluctuate wildly from day to day in the way blood sugar might. They build up over time. If you are taking a subpotent dose for weeks or months, your thyroid-stimulating hormone (TSH) levels will slowly rise as your body struggles to compensate for the lack of T4. This gradual drift can lead to a state known as underactive thyroid, or hypothyroidism. The danger lies in the subtlety of the onset. You might not wake up one day and feel suddenly ill. Instead, you may experience a slow erosion of energy, a slight increase in sensitivity to cold, subtle weight gain despite unchanged habits, or a feeling of brain fog that is easy to dismiss as stress or aging.
For many people, the body can tolerate minor fluctuations because it has a wide buffer zone. However, for others, particularly those with existing heart conditions or those who are elderly, even small deviations in thyroid hormone levels can have serious consequences. Thyroid hormones directly affect heart rate and contractility. A significant drop in effective dosage can lead to bradycardia (abnormally slow heart rate) and, in severe cases, contribute to fluid buildup around the heart or worsening heart failure symptoms. Furthermore, because the brain is highly sensitive to thyroid status, cognitive impacts can be profound, affecting memory, focus, and mood stability. This is why manufacturers like Accord Healthcare and regulators at the FDA take subpotency claims so seriously: it is not just about efficacy; it is about preventing a slow, systemic decline in health that might go unnoticed until it becomes difficult to reverse.
In this specific case involving NDC 16729-458-15 and Lot # D2402337, the risk is tied to the specific manufacturing run from Intas Pharmaceuticals Limited. While the general class of hazard—subpotency—affects anyone relying on precise hormonal control, the impact is most acute for individuals who have no room for error in their dosage. These patients often require their levels to be within a very narrow therapeutic window. When that window shifts due to a subpotent supply, the clinical gap between “treated” and “untreated” opens up, potentially leading to a recurrence of the symptoms that led them to take the medication in the first place.
Who is most at risk
To understand who is truly vulnerable in this recall, we first need to look closely at the product itself. This is not a topical cream or an over-the-counter supplement that might cause a mild stomach upset if taken incorrectly. We are talking about Levothyroxine Sodium Tablets, specifically the 300 mcg (0.3 mg) strength. This is a prescription-only medication, which immediately narrows the field of who possesses it. The individuals at risk are those who have been prescribed thyroid hormone replacement therapy by a healthcare provider. These are people whose bodies cannot produce enough thyroid hormone on their own, a condition known as hypothyroidism. Because the drug is manufactured for Accord Healthcare and distributed nationwide, the pool of potentially affected users is large, but it is specific to those with this particular chronic medical need.
The core of the risk here stems from the nature of the hazard: the drug is "subpotent." This means the tablets contain less of the active ingredient than they are supposed to. For a medication like Levothyroxine, which regulates metabolism, energy levels, heart rate, and body temperature, precision is everything. The thyroid gland acts as the body’s metabolic thermostat, and this pill is designed to keep that thermostat at exactly the right setting. When the dose is lower than labeled, the thermostat fails to rise high enough. For the average adult managing a stable condition, this might result in a slow return of symptoms like fatigue, weight gain, or feeling cold. However, for certain groups, the consequences are far more severe.
The elderly population faces a heightened level of danger. Older adults often have less physiological reserve, meaning their bodies struggle to compensate for hormonal imbalances. A subpotent dose can lead to sudden drops in heart rate and blood pressure, increasing the risk of falls, confusion, or even cardiac events. For individuals with pre-existing heart conditions, who are already on the edge of cardiac stability, this unexpected reduction in thyroid hormone support can trigger serious arrhythmias or exacerbate heart failure symptoms that were previously under control.
Pregnant individuals and those planning to become pregnant are also at significant risk. Thyroid hormones are critical for fetal brain development, especially during the first trimester. A subpotent dose may seem like a minor discrepancy on paper, but in the context of pregnancy, it can have profound implications for the developing baby’s cognitive development. Furthermore, for patients with severe, long-standing hypothyroidism, the body is accustomed to a specific, higher level of hormone support. A sudden reduction in potency can lead to myxedema, a rare but life-threatening condition characterized by extreme lethargy, hypothermia, and loss of consciousness. While any user needs to address this recall, those with complex medical histories, heart disease, or pregnancy-related concerns are the ones who must act with urgency.
How to tell if you have the recalled item
Because Levothyroxine is a critical medication used to treat thyroid conditions, verifying that you do not possess the specific batch affected by this FDA recall is essential for your health and safety. The recall issued by Accord Healthcare, Inc., involves a very precise set of criteria. If you are looking at your medicine cabinet or pharmacy receipt, you need to check several specific details to confirm whether your bottles are part of this recall event. It is not enough to simply see the brand name; the lot number and expiration date are the most critical identifiers here.
First, look for the product name on the bottle label. The recalled item is Levothyroxine Sodium Tablets, USP, with a strength of 300 mcg (which is equivalent to 0.3 mg). This specific dosage is packaged in 90-count bottles that are designated as Prescription Only (Rx Only). It is manufactured for Accord Healthcare, Inc., located in Raleigh, North Carolina, and manufactured by Intas Pharmaceuticals Limited in Selaqui, Dehradun, India. If your bottle has a different manufacturer, a different strength, or a different count (such as 30 or 60 tablets), it is not part of this specific recall, though you should always verify with your pharmacist if you are unsure.
The most important step is to locate the National Drug Code (NDC) and the Lot Number on the packaging. The recalled NDC is 16729-458-15. You will typically find this code printed on the side or back of the bottle label. Next to it, or on the carton box if you still have it, look for the Lot number. The specific lot identified in this recall is D2402337. If your bottle has any other lot number, it is not affected by this action. Additionally, check the expiration date printed on the label. The recalled inventory has an expiration date of 10/31/2026. While the expiration date alone does not confirm the recall, it helps narrow down the batch if you are uncertain about the lot number.
If you have recently filled your prescription, check your pharmacy receipt or contact your pharmacist directly. They can look up the specific lot numbers dispensed to you. Since this product was distributed nationwide within the United States, the location where you purchased it does not determine whether it is recalled; only the manufacturing details matter. Do not rely on the purchase date or price to identify the recall. Even if you bought the medication recently, if the lot number is not D2402337, it is safe from this specific recall. However, if your bottle matches the NDC 16729-458-15 and Lot # D2402337, please do not take any more of this medication until you have consulted with your healthcare provider or pharmacist for further instructions on a remedy or replacement.
What to do — step by step
When you receive news of a drug recall, it is natural to feel a sudden spike of anxiety, especially when the product in question is something as critical as thyroid medication. However, panic is not your best tool right now; careful, methodical action is. Because this specific recall issued by Accord Healthcare, Inc. involves Levothyroxine Sodium Tablets that are subpotent—meaning they may contain less of the active ingredient than labeled—and because the official remedy has not been explicitly stated in the FDA’s public notice, you must take a cautious, proactive approach to ensure your health remains stable. The following steps are designed to help you navigate this situation safely and effectively, prioritizing your medical continuity while you resolve the issue with the manufacturer or distributor. First and foremost, do not stop taking your medication abruptly without consulting your healthcare provider. Levothyroxine is used to treat hypothyroidism, a condition where the thyroid gland does not produce enough hormones. Suddenly discontinuing this medication can lead to a rapid decline in your metabolic function, causing symptoms such as extreme fatigue, weight gain, cold intolerance, and in severe cases, myxedema coma, a life-threatening condition. While the tablets recalled are subpotent rather than toxic, relying on them when they may not be delivering the full dose can cause your thyroid-stimulating hormone (TSH) levels to rise, effectively leaving your condition untreated. Therefore, your immediate priority is to contact your prescribing doctor or pharmacist today. Explain that you have a bottle of Levothyroxine Sodium Tablets, 300 mcg, manufactured by Accord Healthcare, with Lot Number D2402337 and an expiration date of 10/31/2026. Ask them to prescribe a new supply from a different manufacturer or batch right away. Most pharmacies can fill a new prescription immediately, ensuring you do not miss a day of therapy. Second, verify exactly which bottles you possess. The recall applies specifically to Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), sold in 90-count bottles. Check the NDC number on your bottle label; it should be 16729-458-15. Crucially, you must check the lot number printed on the packaging. If your bottle does not have Lot Number D2402337, it is not part of this recall, and you can continue using it as normal. If you do have the affected lot, do not attempt to return the bottles to your pharmacy for a refund on your own yet, as the remedy is not stated. Instead, keep the bottles in a safe place, away from heat and moisture, but do not flush them or throw them in the trash where they might be accessed by others or pets. Third, since the official remedy is not stated, you must initiate contact to understand your options. Reach out to Accord Healthcare, Inc., the company responsible for the recall. You can find their consumer contact information on their official website or through the FDA’s recall database. When you contact them, provide your lot number and expiration date. Ask specifically if they are offering a replacement product from a different batch, a refund, or instructions for safe disposal. If you purchased the medication online, contact the retailer directly as well, providing them with the same details. They may offer an exchange or credit while you wait for guidance from the manufacturer. Finally, monitor your health closely. Because the drug is subpotent, you might not notice immediate changes, but over time, you could experience a return of hypothyroid symptoms. Keep a log of any changes in energy levels, weight, mood, or temperature sensitivity. Share this log with your doctor during your next appointment. They may need to adjust your dosage temporarily until you can get your thyroid levels rechecked via blood work. This recall is a Class II action, indicating that use of the product could cause temporary health problems or pose a slight threat of a serious nature, so treating it with serious attention but without fear is the correct path forward. By staying in close contact with your medical team and the manufacturer, you ensure that this logistical hiccup does not become a health crisis.Your refund, repair, or replacement options
When a product recall occurs, the most immediate and practical question for consumers is often, “What happens next?” In this specific instance involving Accord Healthcare, Inc., the situation requires a bit of honesty: the official FDA record does not explicitly state the specific remedy, such as a refund, repair, or replacement plan. While recalls typically involve one of these standard resolutions, the absence of stated terms in the current documentation means we cannot guarantee what financial or logistical relief you might receive. However, this lack of explicit detail does not mean you are left without guidance on how to proceed.
First, it is important to understand why a remedy might not be immediately listed. In some Class II recalls, particularly those involving pharmaceuticals where the primary hazard is a subpotent drug rather than physical contamination or injury risk, the focus of the agency and the manufacturer is often on stopping distribution and alerting healthcare providers to ensure patient safety through medication substitution, rather than processing individual consumer refunds. Because Levothyroxine is a prescription medication regulated by the FDA, the standard path for resolution usually involves your pharmacist or prescribing physician. They are the ones who can help you navigate the transition to a different lot number or a different manufacturer’s version of the drug, which effectively serves as the “replacement” in this context.
If you have already purchased this specific 90-count bottle of Levothyroxine Sodium Tablets (NDC 16729-458-15) and are seeking a refund directly from the retailer or manufacturer, you will need to take proactive steps since no automatic process is described in the recall notice. You should contact the point of sale where you bought the item. Most major pharmacies and retail distributors have established protocols for handling recalled goods. They may offer a full refund of the purchase price, including any co-pay if you have already submitted it through insurance, though this varies by store policy.
If you are unable to resolve the issue with the retailer, or if you believe you should be compensated directly by Accord Healthcare, Inc., you will need to locate their customer service or quality assurance department. Since the recall notice does not provide a specific phone number or email address for consumer inquiries, you may need to visit the Accord Healthcare website or search for their Raleigh, NC headquarters contact information. Be prepared to provide your proof of purchase, the specific lot number (D2402337), and the expiration date (10/31/2026) when you reach out. Keep in mind that because the hazard is a subpotent drug, the urgency lies more in ensuring you are not taking an ineffective dose than in recovering the cost of the bottle itself. Your health provider is your best ally here, as they can monitor your thyroid levels to ensure your treatment remains effective while you sort out the logistical details of returning the product.
What can happen if you ignore it
When a medication like Levothyroxine Sodium is recalled for being subpotent, the danger is not always immediate or dramatic. It does not typically cause an acute allergic reaction or sudden toxicity. Instead, the risk is insidious, creeping in through a slow, untreated decline in your body’s metabolic function. Levothyroxine is a synthetic form of thyroxine, a hormone that your thyroid gland naturally produces to regulate how your cells use energy. It is critical for maintaining your heart rate, body temperature, and overall metabolic rhythm. When the drug is subpotent, it means the tablets contain less of the active ingredient than they should. For a patient relying on a precise 300 mcg dose to keep their thyroid levels stable, receiving less hormone than prescribed is like trying to fill a gas tank with a hole in the bottom. You are putting fuel in, but not enough to make the engine run correctly. The most immediate consequence of ignoring this issue is the return of hypothyroidism symptoms, even if you have been successfully managing them for years. Because your body has adjusted to the previous, correct dosage, it expects a certain level of hormonal support. When that support drops unexpectedly, your metabolism slows down. You might notice a fatigue that sleep does not fix, or a feeling of coldness when others are comfortable. These are not just minor inconveniences; they are signals that your bodily systems are struggling to maintain homeostasis. Over time, untreated hypothyroidism can lead to more serious complications. Your cholesterol levels may rise, increasing the risk of heart disease. Your heart rate might slow dangerously (bradycardia), and you could experience muscle weakness or joint pain that interferes with daily activities. For individuals with pre-existing heart conditions, the stakes are higher. Thyroid hormones play a direct role in the strength and rhythm of your heartbeat. A sudden drop in effective medication dosage can strain the cardiovascular system, potentially leading to irregular heartbeats or worsening heart failure symptoms. While the recall notice does not report specific injuries, medical experts warn that the unpredictability of subpotent drugs makes it impossible to know exactly how much your thyroid levels have dropped without testing. You might feel "fine" initially, but blood tests would likely show elevated TSH (thyroid-stimulating hormone) levels, indicating your pituitary gland is screaming for more hormone. Ignoring the recall means accepting this unknown variable in your health management. It leaves you vulnerable to a gradual decline that could require much more intensive medical intervention to reverse later. Do not wait for symptoms to become severe; the goal of taking thyroid medication is prevention of these very outcomes, and using a compromised product undermines that entire purpose.Staying safe: broader tips
While this specific recall involves a single lot of levothyroxine tablets distributed by Accord Healthcare, the incident serves as a timely reminder that medication safety is an ongoing practice rather than a one-time event. When it comes to prescription drugs, particularly those that manage chronic conditions like thyroid disorders, vigilance is your best defense. The most effective way to stay safe is to establish a routine for checking the status of your medications. You should regularly visit the FDA’s official website or subscribe to their email alert system. These resources provide immediate notifications about new recalls, allowing you to act before a potential issue affects your health. By staying informed, you transform from a passive consumer into an active participant in your own healthcare safety.
Another critical step is understanding how to read and interpret drug labels and packaging. Always keep the original labeling for any medication you take, especially those that are "Rx Only" or have specific storage requirements. When you receive a refill or a new prescription, take a moment to verify the National Drug Code (NDC), lot number, and expiration date against your records or any recall notices you may have received. If a manufacturer contacts you directly or if news breaks about a batch issue, having this information readily available can save valuable time and reduce anxiety. Do not throw away packaging until you are certain the product is safe, as it contains the essential identifiers needed for verification.
Beyond checking for recalls, proper medication management at home plays a significant role in safety. Store your medications exactly as directed on the label. For many drugs, this means keeping them in a cool, dry place away from direct sunlight and humidity, such as a bedroom closet rather than a bathroom cabinet. Improper storage can degrade the chemical stability of a drug, potentially rendering it subpotent or even harmful over time, much like the hazard described in this recall. Additionally, never share prescription medications with others. Your unique dosage needs and medical history mean that what is safe for one person may be ineffective or dangerous for another.
Finally, maintain open communication with your healthcare provider and pharmacist. If you ever notice changes in how a medication seems to work—such as symptoms returning despite consistent use—it could indicate an issue with the drug’s potency or quality. Report any concerns immediately. Building a relationship with your pharmacist can also help; they are often the first to know about industry-wide issues or shortages and can offer guidance on alternative treatments if necessary. By combining regular checks, proper storage, and professional communication, you create a robust safety net that protects you regardless of where a specific product comes from.